"Iris Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.
| Descriptor ID |
D015811
|
| MeSH Number(s) |
C04.588.364.978.400 C11.319.494.400 C11.941.375.375 C11.941.855.400
|
| Concept/Terms |
Iris Neoplasms- Iris Neoplasms
- Neoplasms, Iris
- Iris Neoplasm
- Neoplasm, Iris
|
Below are MeSH descriptors whose meaning is more general than "Iris Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Iris Neoplasms".
This graph shows the total number of publications written about "Iris Neoplasms" by people in this website by year, and whether "Iris Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 0 | 4 |
| 1996 | 3 | 0 | 3 |
| 1997 | 3 | 1 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 4 | 0 | 4 |
| 2001 | 3 | 0 | 3 |
| 2002 | 4 | 0 | 4 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 5 | 0 | 5 |
| 2012 | 2 | 0 | 2 |
| 2013 | 4 | 0 | 4 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 1 | 4 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 0 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Iris Neoplasms" by people in Profiles.
-
Dockery PW, DeSimone JD, Liu CK, Achuck K, Hamburger J, Bas Z, Shields CL. Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approaches. Can J Ophthalmol. 2024 Oct; 59(5):329-334.
-
Bas Z, Yaghy A, Shields CL. Iris melanoma with neovascularization in sector melanocytosis controlled with 125I plaque radiotherapy and bevacizumab. J Fr Ophtalmol. 2021 May; 44(5):738-739.
-
Xu TT, Pulido JS, Deufel CL, Corbin KS, Petersen IA, Dalvin LA. Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma. Eye (Lond). 2021 10; 35(10):2754-2762.
-
Mudhar HS, Milman T, Eagle RC, Sanderson T, Pheasey L, Paine S, Salvi S, Rennie IG, Rundle P, Shields CL, Shields JA. Usefulness of PAX8 Immunohistochemistry in?Adult Intraocular Tumor Diagnosis. Ophthalmology. 2021 05; 128(5):765-778.
-
Ang SM, Dalvin LA, Emrich J, Komarnicky L, Shields JA, Shields CL. Plaque Radiotherapy for Medulloepithelioma in 6 Cases From a Single Center. Asia Pac J Ophthalmol (Phila). 2019 Jan-Feb; 8(1):30-35.
-
Shields JA, Shields CL, Lally SE, Milman T, Eagle RC. Iris Melanoma in a Child Simulating Juvenile Xanthogranuloma. Middle East Afr J Ophthalmol. 2018 Apr-Jun; 25(2):115-117.
-
Shields CL, Di Nicola M, Bekerman VP, Kaliki S, Alarcon C, Fulco E, Shields JA. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients. Ophthalmology. 2018 06; 125(6):913-923.
-
Chien JL, Sioufi K, Ferenczy S, Say EAT, Shields CL. Optical Coherence Tomography Angiography Features of Iris Racemose Hemangioma in 4 Cases. JAMA Ophthalmol. 2017 10 01; 135(10):1106-1110.
-
Harley MR, Rao R, Lally SE, Shields CL. Malignant transformation of multifocal tapioca iris nevus in a child. J AAPOS. 2017 Aug; 21(4):340-342.
-
Shields CL, Lally SE, Manjandavida FP, Leahey AM, Shields JA. Diffuse Anterior Retinoblastoma with Globe Salvage and Visual Preservation in 3 Consecutive Cases. Ophthalmology. 2016 Feb; 123(2):378-384.